<p><b>A</b>: The histogram shows the size distribution of visceral leishmaniasis clinical trials. Bars are coloured according to the region in which the trials were conducted. <b>B</b>: The cumulative enrolment of patients into clinical trials is shown as a function of the year in which the trial results were published. Data are divided according to the location at which the patients were enrolled.</p
<p>Data extracted from 127 clinical records in 7 hospitals in Morocco. Mean and 95% Confidence Inter...
<p>Patient enrolment in a Phase 2 study of visceral leishmaniasis with triangular design.</p
Solid circles represent classical CL and VL leishmaniasis, and solid triangles represent atypical CL...
<p>The cumulative enrolment of patients into clinical studies of VL drugs is shown as a function of ...
Location map of the study area, presenting the average number of visceral leishmaniasis (VL) cases p...
<p>Panel A shows the number of VL cases and non-cases tested by month. Panel B shows the age and sex...
Age distribution of all visceral leishmaniasis (VL) cases detected between 2007 and 2015 living with...
<p>Data related to the clinical management of VL patients: days in hospital, days of VL treatment, n...
<p>Distribution of blood donors for each test employed for <i>Leishmania</i> sp. detection in compar...
The dashed line represents the WHO 2020 elimination target [10]. Top right panel: distribution of VL...
The years with an Asterix (*) represent significant spatial autocorrelation of VL incidence between ...
<p>Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical ...
Data collection containing: [1] Odds ratios for VL and asymptomatic infection risk based on proximit...
The black dashed line in panel B represents the cut-off value for an ‘outbreak’, where at least thre...
<p>Left map: Annual incidence of visceral leishmaniasis (VL) in Sudan (2011) from < 5 cases /100,000...
<p>Data extracted from 127 clinical records in 7 hospitals in Morocco. Mean and 95% Confidence Inter...
<p>Patient enrolment in a Phase 2 study of visceral leishmaniasis with triangular design.</p
Solid circles represent classical CL and VL leishmaniasis, and solid triangles represent atypical CL...
<p>The cumulative enrolment of patients into clinical studies of VL drugs is shown as a function of ...
Location map of the study area, presenting the average number of visceral leishmaniasis (VL) cases p...
<p>Panel A shows the number of VL cases and non-cases tested by month. Panel B shows the age and sex...
Age distribution of all visceral leishmaniasis (VL) cases detected between 2007 and 2015 living with...
<p>Data related to the clinical management of VL patients: days in hospital, days of VL treatment, n...
<p>Distribution of blood donors for each test employed for <i>Leishmania</i> sp. detection in compar...
The dashed line represents the WHO 2020 elimination target [10]. Top right panel: distribution of VL...
The years with an Asterix (*) represent significant spatial autocorrelation of VL incidence between ...
<p>Pie chart and table showing diagnostic methods used in published visceral leishmaniasis clinical ...
Data collection containing: [1] Odds ratios for VL and asymptomatic infection risk based on proximit...
The black dashed line in panel B represents the cut-off value for an ‘outbreak’, where at least thre...
<p>Left map: Annual incidence of visceral leishmaniasis (VL) in Sudan (2011) from < 5 cases /100,000...
<p>Data extracted from 127 clinical records in 7 hospitals in Morocco. Mean and 95% Confidence Inter...
<p>Patient enrolment in a Phase 2 study of visceral leishmaniasis with triangular design.</p
Solid circles represent classical CL and VL leishmaniasis, and solid triangles represent atypical CL...